No Data
No Data
Express News | Nyxoah Announced That It Has Signed a €37.5M Loan Facility Agreement With the European Investment Bank
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement With the European Investment Bank
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA
Nyxoah Submits Final Module of Premarket Approval Application for Sleep Apnea Therapy to FDA
Nyxoah (NYXH) said Monday it has submitted the final module of its premarket approval application for its Genio sleep apnea therapy to the US Food and Drug Administration. Genio is a hypoglossal nerve
H.C. Wainwright Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $18
H.C. Wainwright analyst Edward White maintains $Nyxoah SA(NYXH.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success rate of 28.1% and a t
Nyxoah Submits Final Module for FDA Approval of Innovative Sleep Apnea Treatment
"Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Compa
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am ET – ("Nyxoah" or the "Company"), a medical technology company focused on
No Data